Summary
It is controversial whether daily occupational exposure to halothane stimulates (induces) the hepatic microsomal enzyme function in man.
We investigated two groups of persons with different degrees of exposure to halothane: Six technicians who for years had been employed with repair and control of anesthesiologic equipment resulting in exposure to about 7 ppm of halothane and 50 ppm of nitrous oxide, and seven anesthesiologists exposed during months to about 2 ppm of halothane and 75 ppm of nitrous oxide.
The clearance of antipyrine was determined from saliva concentrations before and 4 wk after discontinuation of exposure. Matched control persons were investigated simultaneously.
No significant differences were found between the half-life, apparent volume of distribution, or clearance of antipyrine either within the groups or between the groups.
If the antipyrine data from both exposure groups are compared to those of the control groups, the data exclude (95% confidence limit) that antipyrine metabolism increased by more than 3% during exposure to waste anesthetics. This indicates that occupational exposure to halothane in concentrations above the proposed maximal time weighted average concentration of 2 ppm does not change the microsomal activity.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ballinger B, Browning M, O'Malley K, Stevenson IH (1972) Drug-metabolizing capacity in states of drug dependence and withdrawal. Br J Pharmacol 45:638–643
Berner O (1978) Concentration and elimination of anesthetic gases in operating theatres. Acta Anesth Scand 22:46–54
Berner O (1978) Concentration and elimination of anesthetic gases in recovery rooms. Acta Anesth Scand 22:55–57
Brown BR Jr, Sagalyn AM (1974) Hepatic microsomal enzyme induction by inhalation anesthetics. Anesthesiology 40:152–161
Cahalan MK, Johnson BH, Eger El (1981) Relationship of concentration of halothane and enflurane to their metabolism and elimination in man. Anesthesiology 54:3–8
Cascorbi HF (1974) Factors causing differences in halothane biotransformation. Int Anesth Clin 12:63–71
Duvaldestin P, Mazze RI, Nivoche Y, Desmonts JM (1981) Occupational exposure to halothane results in enzyme induction in anesthetists. Anesthesiology 54:57–60
Edwards OM, Courtenay-Evans RJ, Galley IM, Hunter J, Tait AD (1974) Changes in cortisol metabolism following rifampicin therapy. Lancet 2:549–551
Farrel GC, Cooksley WGE, Powell LW (1979) Enhancement of hepatic drug metabolism by glutethimide in patients with liver disease. Eur J Clin Pharmacol 16:113–117
Goss JE, Dickhaus DW (1965) Increased bishydroxycoumarin requirements in patients receiving phenobarbital. New Engl J Med 273:1094–1095
Greisen G, Andreasen PB (1976) Two compartment analysis of plasma elimination of phenazone in normals and in patients with cirrhosis of the liver. Acta Pharmacol Toxicol 38:49–58
Harman AW, Russet WJ, Frewin DB, Priestly BG (1978) Altered drug metabolism in anaesthetists exposed to volatile anaesthetic agents. Anaest Intens Care 6:210–214
Hitt BA, Mazzie RI, Stevens WC, White A, Eger El (1975) Species, strain, sex and individual differences in enflurane metabolism. Br J Anaesth 47:1157–1161
Lai AA, Levy RH, Cutler RE (1978) Time-course of interaction between carbamazepine and clonazepam in normal man. Clin Pharmacol Ther 24:316–323
Linde HW, Bergman ML (1971) Nonspecific stimulation of drug metabolizing enzymes by inhalation anesthetic agents. Anesth Analg Curr Res 50:656–665
Nagy M (1974) Caffeine content of beverages and chocolate. J Am Med Ass 229:337
Nimmo WS, Thompson PG, Prescott LF (1981) Microsomal enzyme induction after halothane anaesthesia. Br J Clin Pharmacol 12:433–434
NIOSH manual of analytical methods (1977) US Dep of Health, 2nd edn. Education and Wellfare DHEW-publication, no. 77-157-6; methods no. 112 and 117
Prescott LF, Adhpon-Yamoah KK, Roberts E (1973) Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol 25:205–207
Reynolds ES, Moslen MT (1974) Liver injury following halothane anaesthesia in phenobarbital-pretreated rats. Biochem Pharmacol 23:189–195
Sipes IG, Brown BR (1976) An animal model of hepatotoxicity associated with halothane anaesthesia. Anesthesiology 45:622–628
Toverud EL, Boobis AR, Brodie MJ, Murray S, Bennett PN, Whitmarsh V, Davies DS (1981) Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol 21:155–160
Vesell ES (1979) The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 26:275–286
Weisburger EK (1980) Metabolism and activation of chemical carcinogens. Mol Cell Biochem 32:95–114
Wood M, O'Malley K, Stevenson IH (1974) Drug metabolizing ability in operating theatre personnel. Br J Anaesth 46:726–728
Zauder H (1979) A possible interaction of PBC and halothane in man. Anesthesiology 51:95–96
Author information
Authors and Affiliations
Additional information
Supported with grants from the Danish Working Environment Fund
Rights and permissions
About this article
Cite this article
Døssing, M., Weihe, P. Hepatic microsomal enzyme function in technicians and anesthesiologists exposed to halothane and nitrous oxide. Int. Arch Occup Environ Heath 51, 91–98 (1982). https://doi.org/10.1007/BF00378414
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00378414